Real-World Osilodrostat Effectiveness and Safety in Nonpituitary Cushing SyndromeAntoine Tabarin, Nicolas Scheyer, Hervé Lefèbvre et al.|The Journal of Clinical Endocrinology & Metabolism|2025Cited by 4
12275 Effect Of Osilodrostat On Cardiovascular And Metabolic Manifestations Of Hypercortisolism In Patients With Non-Pituitary Cushing’s Syndrome: Findings From A Retrospective Observational Study (LINC 7)N Scheyer, A. Tabarin, Jérôme Bertherat et al.|Journal of the Endocrine Society|2024Cited by 2